173 -12 (74) 2024 - Nuriddinova N.F. - QUANTITATIVE CHANGES OF PLATES IN HCV ETIOLOGY CHRONIC HEPATITIS AND LIVER CIRRHOSIS ON THE BASE OF ANTIVIRUS THERAPY

QUANTITATIVE CHANGES OF PLATES IN HCV ETIOLOGY CHRONIC HEPATITIS AND LIVER CIRRHOSIS ON THE BASE OF ANTIVIRUS THERAPY

Nuriddinova N.F. - Tashkent Medical Academy

Resume

Today, approximately 300 million on Earth.more than 500 million people were infected with parenteral hepatitis viruses. many people from non-clinical virus have a carrying capacity. In hepatocytes of the liver, the activity of both systems is interconnected due to the production of many coagulation factors, anticoagulant proteins, components of the fibrinolysis system and important factors of the hemostasis system that stimulate thrombopoiesis. The observation of complications such as hematomas, hemorrhagic purpura, bleeding from the nose and gums, menorrhagia in patients with chronic diffuse liver failure remains an urgent clinical problem to this day. Purpose: Assessment of the amount and morphology of platelets against the background of anti-virus therapy in chronic hepatitis and liver cirrhosis with HCV etiology. Data from 2020-2023 in the Departments of Hematology and Hepatobiliary pathology of the 1st Clinic of the Tashkent Medical Academy, HCV etiology was treated with chronic hepatitis and cirrhosis of the liver.

Key words: chronic hepatitis, liver cirrhosis, platelet, anisocytosis, thrombocytogram.

First page

901

Last page

905

For citation:Nuriddinova N.F. - QUANTITATIVE CHANGES OF PLATES IN HCV ETIOLOGY CHRONIC HEPATITIS AND LIVER CIRRHOSIS ON THE BASE OF ANTIVIRUS THERAPY//New Day in Medicine 12(74)2024 901-905 https://https://newdayworldmedicine.com/en/new_day_medicine/12-74-2024

List of References

1. Устинова М.Н. Агрегация тромбоцитов у больных хроническими диффузными заболеваниями печени и ее коррекция внутривенной озонотерапией: автореф. дис. кан. мед.наук. – Москва, 2005; 25.
2. Kurbonova Z.Ch. Features of hemostatic system disorders in patients with chronic hepatitis and liver cirrhosis of viral etiology 14.00.29-Hematology and transfusiology. /Author's abstract. dis. ...cand. honey. Sci. Tashkent 2019; 45 p.
3. Serov V.V., Bushueva N.V., Ignatova T.M., Aprosina Z.G. Viral and host factors in the development and progression of chronic viral hepatitis C and B //Russian Journal of Gastroenterology, Hepatology and Coloproctology. 2006;4:12-23.
4. Babadjanova Sh.A., Zaynutdinova D.L. Frequency and characteristics of immune thrombocytopenia at different stages of pregnancy //Nazariy va klinik tibbiyot jurnali. 2021;5:9-12. ISSN 2091-5853.
5. Batirova A.S., Bakanov M.I., Surkov A.N. The modern concepts of hemostasis system under Chronicdiseases of liver: the publication review //Klin. Lab. Diagn. 2015;60(8):40-44.
6. Caldwell S.H., Hoffman M., Lisman T.et al. Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management //Hepatology. 2006;44:44.
7. Hollestelle M.J., Geertzen H.G.M., Straatsburg I.H., van Gulik T.M., van Mourik J.A. Factor VIII expression in liver disease //Thromb Haemost. 2004;91:267-275.
8. Huard G., Bilodeau M. Management of anticoagulation for portal vein thrombosis in individuals with cirrhosis: A systematic review //Int.J.Hepatol. 2012; 6-7.
9. Iancu R.I., Iancu D., Murărescu D., Nechifor M., Costuleanu M. Platelet functions in acute and chronic experimentally induced hepatopathia //Rev.Med.Chir.Soc.Med.Nat.Iasi. 2010;114(4):1101-1106.
10. Kurokawa T., Ohkohchi N. Platelets in liver disease, cancer and regeneration //World J.Gastroenterol.–2017;23(18):3228-3239.
11. Park D.K., Um S.H., Lee J.W. et. al. Clinical significance of variceal hemorrhage in recent years in patients with liver cirrhosis and esophageal varices //J. Gastroenterol. Hepatol. 2004;19(9):1024-1051.
12. Sayed D., Amin N.F., Galal G.M. Monocyte–platelet aggregates and platelet micro–particles in patients with post–hepatitic liver cirrhosis //Thromb Res. 2010;125(5):228-233.

    file

    download